A proof of concept for biomarker-guided targeted therapy against ovarian cancer based on patient-derived tumor xenografts

MLA

Joshua M. Korn, et al. A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts. Aug. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d91b75e0a12ace48a2f8fbf694a67007&authtype=sso&custid=ns315887.

APA

Joshua M. Korn, Ronald Meyer, Juliet Williams, Colleen Kowal, Roberto Velazquez, Paul Fordjour, Esther Kurth, Adam C. Palmer, Hans Bitter, Xiamei Zhang, Deborah Plana, GiNell Elliott, Margaret E. McLaughlin, Alice Loo, Julie Muszynski, David A. Ruddy, William R. Sellers, Daniel P. Rakiec, Stacy Rivera, … John Green. (2020). A proof of concept for biomarker-guided targeted therapy against ovarian cancer based on patient-derived tumor xenografts.

Chicago

Joshua M. Korn, Ronald Meyer, Juliet Williams, Colleen Kowal, Roberto Velazquez, Paul Fordjour, Esther Kurth, et al. 2020. “A Proof of Concept for Biomarker-Guided Targeted Therapy against Ovarian Cancer Based on Patient-Derived Tumor Xenografts,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....d91b75e0a12ace48a2f8fbf694a67007&authtype=sso&custid=ns315887.